Literature DB >> 24582666

Invoking the power of thrombospondins: regulation of thrombospondins expression.

Olga Stenina-Adognravi1.   

Abstract

Increasing evidence suggests critical functions of thrombospondins (TSPs) in a variety of physiological and pathological processes. With the growing understanding of the importance of these matricellular proteins, the need to understand the mechanisms of regulation of their expression and potential approaches to modulate their levels is also increasing. The regulation of TSP expression is multi-leveled, cell- and tissue-specific, and very precise. However, the knowledge of mechanisms modulating the levels of TSPs is fragmented and incomplete. This review discusses the known mechanisms of regulation of TSP levels and the gaps in our knowledge that prevent us from developing strategies to modulate the expression of these physiologically important proteins.
Copyright © 2014 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Regulation of expression; Thrombospondin; Transcription; Translation; miRNA

Mesh:

Substances:

Year:  2014        PMID: 24582666      PMCID: PMC4143502          DOI: 10.1016/j.matbio.2014.02.001

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  215 in total

1.  Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes.

Authors:  J T Hecht; E Hayes; M Snuggs; G Decker; D Montufar-Solis; K Doege; F Mwalle; R Poole; J Stevens; P J Duke
Journal:  Matrix Biol       Date:  2001-07       Impact factor: 11.583

2.  Slowdown promotes muscle integrity by modulating integrin-mediated adhesion at the myotendinous junction.

Authors:  Eliezer Gilsohn; Talila Volk
Journal:  Development       Date:  2010-01-28       Impact factor: 6.868

3.  Rapid insulin-like growth factor-1-induced changes in granulosa cell thrombospondin-1 expression in vitro.

Authors:  A J Robert McGray; Timothy Gingerich; James J Petrik; Jonathan LaMarre
Journal:  J Reprod Dev       Date:  2011-02       Impact factor: 2.214

4.  The human thrombospondin 3 gene: analysis of transcription initiation and an alternatively spliced transcript.

Authors:  K W Adolph; P Bornstein
Journal:  Mol Cell Biol Res Commun       Date:  1999-07

Review 5.  The role of the thrombospondins in healing myocardial infarcts.

Authors:  Khaled Chatila; Guofeng Ren; Ying Xia; Peter Huebener; Marcin Bujak; Nikolaos G Frangogiannis
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2007-01

6.  Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas.

Authors:  Yanhui Liu; Jesse Chung-sean Pang; Shumin Dong; Boyong Mao; Wai Sang Poon; Ho-keung Ng
Journal:  Hum Pathol       Date:  2005-04       Impact factor: 3.466

7.  Expression of constitutively active cGMP-dependent protein kinase prevents glucose stimulation of thrombospondin 1 expression and TGF-beta activity.

Authors:  Shuxia Wang; Xing Wu; Thomas M Lincoln; Joanne E Murphy-Ullrich
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

8.  Effects of alpha-difluoromethylornithine on thrombospondin-1 production by human breast cancer cells.

Authors:  Andrea Manni; Terry Rager; Scot R Kimball; Leonard S Jefferson; Sharlene Washington; Xin Hu; Michael F Verderame
Journal:  Int J Oncol       Date:  2007-11       Impact factor: 5.650

9.  Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion.

Authors:  Teng-nan Lin; Gyoeng-Moon Kim; Jean-Ju Chen; Wai-Mui Cheung; Yong Y He; Chung Y Hsu
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914

10.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

View more
  29 in total

Review 1.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

Review 2.  Thrombospondin-4 in tissue remodeling.

Authors:  Olga Stenina-Adognravi; Edward F Plow
Journal:  Matrix Biol       Date:  2017-11-11       Impact factor: 11.583

3.  Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.

Authors:  Joanne E Murphy-Ullrich
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

4.  HIF-1α represses the expression of the angiogenesis inhibitor thrombospondin-2.

Authors:  Susan C MacLauchlan; Nicole E Calabro; Yan Huang; Meenakshi Krishna; Tara Bancroft; Tanuj Sharma; Jun Yu; William C Sessa; Frank Giordano; Themis R Kyriakides
Journal:  Matrix Biol       Date:  2017-08-05       Impact factor: 11.583

Review 5.  Integration of pro- and anti-angiogenic signals by endothelial cells.

Authors:  Shideh Kazerounian; Jack Lawler
Journal:  J Cell Commun Signal       Date:  2017-12-20       Impact factor: 5.782

6.  Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology.

Authors:  Alex Helkin; Kristopher G Maier; Vivian Gahtan
Journal:  Biochem Biophys Res Commun       Date:  2015-07-11       Impact factor: 3.575

Review 7.  Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions.

Authors:  Maria A Gubbiotti; Sylvain D Vallet; Sylvie Ricard-Blum; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-09-30       Impact factor: 11.583

Review 8.  Thrombospondin-1 interactions regulate eicosanoid metabolism and signaling in cancer-related inflammation.

Authors:  Manuel U Ramirez; Elizabeth R Stirling; Nancy J Emenaker; David D Roberts; David R Soto-Pantoja
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

9.  Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma.

Authors:  Ailing Lu; Manuel A Pallero; Weiqi Lei; Huixian Hong; Yang Yang; Mark J Suto; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2016-01-20       Impact factor: 4.307

10.  Matrix regeneration proteins in the hypoxia-triggered exosomes of shoulder tenocytes and adipose-derived mesenchymal stem cells.

Authors:  Finosh G Thankam; Isaiah Chandra; Connor Diaz; Matthew F Dilisio; Jonathan Fleegel; R Michael Gross; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2019-12-03       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.